{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T15:08:47Z","timestamp":1790003327033,"version":"4.0.1"},"reference-count":72,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001717","name":"Universiteit Leiden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001717","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021821","name":"Oncode Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021821","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004622","name":"KWF Dutch Cancer Society","doi-asserted-by":"publisher","award":["11079"],"award-info":[{"award-number":["11079"]}],"id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Methods"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.crmeth.2026.101533","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T14:33:01Z","timestamp":1784730781000},"page":"101533","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficient generation of human cDC1-like cells to detect and enhance tumor-reactive T cells via CD4+ T cell help"],"prefix":"10.1016","volume":"6","author":[{"given":"Yizhi","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"de Wit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Schrama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marij J.P.","family":"Welters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karel","family":"van Leeuwen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sander","family":"de Kivit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"de Boer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jitske","family":"van den Bulk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noel F.C. C.","family":"de Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ton N.","family":"Schumacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8043-5009","authenticated-orcid":false,"given":"Jannie","family":"Borst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1755-1709","authenticated-orcid":false,"given":"Yanling","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.crmeth.2026.101533_bib1","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/nri1845","article-title":"Dendritic cells in a mature age","volume":"6","author":"Reis e Sousa","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.crmeth.2026.101533_bib2","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1146\/annurev-immunol-020711-075049","article-title":"The Varieties of Immunological Experience: Of Pathogens, Stress, and Dendritic Cells","volume":"33","author":"Pulendran","year":"2015","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.crmeth.2026.101533_bib3","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1146\/annurev-immunol-020711-074950","article-title":"The Dendritic Cell Lineage: Ontogeny and Function of Dendritic Cells and Their Subsets in the Steady State and the Inflamed Setting","volume":"31","author":"Merad","year":"2013","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.crmeth.2026.101533_bib4","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1002\/eji.202149632","article-title":"Human dendritic cell subsets: An updated view of their ontogeny and functional specialization","volume":"52","author":"Segura","year":"2022","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.crmeth.2026.101533_bib5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/imm.12888","article-title":"Human dendritic cell subsets: an update","volume":"154","author":"Collin","year":"2018","journal-title":"Immunology"},{"key":"10.1016\/j.crmeth.2026.101533_bib6","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.immuni.2019.08.008","article-title":"Single-Cell Analysis of Human Mononuclear Phagocytes Reveals Subset-Defining Markers and Identifies Circulating Inflammatory Dendritic Cells","volume":"51","author":"Dutertre","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.crmeth.2026.101533_bib7","doi-asserted-by":"crossref","DOI":"10.1126\/science.aah4573","article-title":"Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes and progenitors","volume":"356","author":"Villani","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.crmeth.2026.101533_bib8","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1084\/jem.20030323","article-title":"Flt3 Ligand Regulates Dendritic Cell Development from Flt3+ Lymphoid and Myeloid-committed Progenitors to Flt3+ Dendritic Cells In Vivo","volume":"198","author":"Karsunky","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.crmeth.2026.101533_bib9","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1146\/annurev-immunol-032713-120204","article-title":"Transcriptional Control of Dendritic Cell Development","volume":"34","author":"Murphy","year":"2016","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.crmeth.2026.101533_bib10","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.immuni.2020.07.003","article-title":"Differential IRF8 Transcription Factor Requirement Defines Two Pathways of Dendritic Cell Development in Humans","volume":"53","author":"Cytlak","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.crmeth.2026.101533_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2015.00129","article-title":"The known unknowns of the human dendritic cell network","volume":"6","author":"Durand","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.crmeth.2026.101533_bib12","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1158\/2326-6066.CIR-15-0041","article-title":"The Emerging Understanding of Myeloid Cells as Partners and Targets in Tumor Rejection","volume":"3","author":"Broz","year":"2015","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.crmeth.2026.101533_bib13","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ccell.2016.06.003","article-title":"Critical Role for CD103 +\/CD141 + Dendritic Cells Bearing CCR7 for Tumor Antigen Trafficking and Priming of T Cell Immunity in Melanoma","volume":"30","author":"Roberts","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.crmeth.2026.101533_bib14","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1084\/jem.192.12.1685","article-title":"Cd8+ but Not Cd8\u2212 Dendritic Cells Cross-Prime Cytotoxic T Cells in Vivo","volume":"192","author":"den Haan","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.crmeth.2026.101533_bib15","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1016\/j.immuni.2021.08.026","article-title":"Conventional type I dendritic cells maintain a reservoir of proliferative tumor-antigen specific TCF-1+ CD8+ T cells in tumor-draining lymph nodes","volume":"54","author":"Schenkel","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.crmeth.2026.101533_bib16","doi-asserted-by":"crossref","first-page":"4996","DOI":"10.1016\/j.cell.2021.08.020","article-title":"Antigen dominance hierarchies shape TCF1+ progenitor CD8 T cell phenotypes in tumors","volume":"184","author":"Burger","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.crmeth.2026.101533_bib17","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/j.ccell.2021.10.008","article-title":"Myeloid antigen-presenting cell niches sustain antitumor T cells and license PD-1 blockade via CD28 costimulation","volume":"39","author":"Duraiswamy","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.crmeth.2026.101533_bib18","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.immuni.2022.12.002","article-title":"CD8+ T cell activation in cancer comprises an initial activation phase in lymph nodes followed by effector differentiation within the tumor","volume":"56","author":"Prokhnevska","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.crmeth.2026.101533_bib19","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-35615-5","article-title":"CD4+ helper T cells endow cDC1 with cancer-impeding functions in the human tumor micro-environment","volume":"14","author":"Lei","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.crmeth.2026.101533_bib20","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1038\/s41590-022-01324-w","article-title":"Mechanisms of CD40-dependent cDC1 licensing beyond costimulation","volume":"23","author":"Wu","year":"2022","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.crmeth.2026.101533_bib21","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/s41577-018-0044-0","article-title":"CD4+ T cell help in cancer immunology and immunotherapy","volume":"18","author":"Borst","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.crmeth.2026.101533_bib22","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/s41423-024-01133-1","article-title":"CD4+ T cells produce IFN-I to license cDC1s for induction of cytotoxic T-cell activity in human tumors","volume":"21","author":"Lei","year":"2024","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.crmeth.2026.101533_bib23","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/s41586-020-2611-3","article-title":"cDC1 prime and are licensed by CD4+ T cells to induce anti-tumour immunity","volume":"584","author":"Ferris","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.crmeth.2026.101533_bib24","doi-asserted-by":"crossref","DOI":"10.1126\/science.adq1405","article-title":"A distinct priming phase regulates CD8 T cell immunity by orchestrating paracrine IL-2 signals","volume":"388","author":"Jobin","year":"2025","journal-title":"Science"},{"key":"10.1016\/j.crmeth.2026.101533_bib25","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.immuni.2017.10.009","article-title":"CD4+T Cell Help Confers a Cytotoxic T Cell Effector Program Including Coinhibitory Receptor Downregulation and Increased Tissue Invasiveness","volume":"47","author":"Ahrends","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.crmeth.2026.101533_bib26","doi-asserted-by":"crossref","first-page":"5531","DOI":"10.1038\/s41467-019-13438-1","article-title":"CD4+ T cell help creates memory CD8+ T cells with innate and help-independent recall capacities","volume":"10","author":"Ahrends","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.crmeth.2026.101533_bib27","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.ccell.2017.04.003","article-title":"Tumor-Residing Batf3 Dendritic Cells Are Required for Effector T Cell Trafficking and Adoptive T Cell Therapy","volume":"31","author":"Spranger","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.crmeth.2026.101533_bib28","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/j.ccell.2023.06.008","article-title":"A distinct stimulatory cDC1 subpopulation amplifies CD8+ T cell responses in tumors for protective anti-cancer immunity","volume":"41","author":"Meiser","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.crmeth.2026.101533_bib29","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/s43018-020-0075-x","article-title":"PD-L1 expression by dendritic cells is a key regulator of T-cell immunity in cancer","volume":"1","author":"Oh","year":"2020","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.crmeth.2026.101533_bib30","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1056\/NEJMoa1910836","article-title":"Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma","volume":"381","author":"Larkin","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.crmeth.2026.101533_bib31","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1056\/NEJMoa1501824","article-title":"Pembrolizumab for the Treatment of Non\u2013Small-Cell Lung Cancer","volume":"372","author":"Garon","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.crmeth.2026.101533_bib32","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1093\/annonc\/mdz011","article-title":"Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001","volume":"30","author":"Hamid","year":"2019","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.crmeth.2026.101533_bib33","doi-asserted-by":"crossref","first-page":"5482","DOI":"10.1016\/j.cell.2021.09.014","article-title":"Atlas of clinically distinct cell states and ecosystems across human solid tumors","volume":"184","author":"Luca","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.crmeth.2026.101533_bib34","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1126\/science.aaa4967","article-title":"Adoptive cell transfer as personalized immunotherapy for human cancer","volume":"348","author":"Rosenberg","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.crmeth.2026.101533_bib35","article-title":"Engineered TCR-T Cell Immunotherapy in Anticancer Precision Medicine: Pros and Cons","volume":"12","author":"Zhao","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.crmeth.2026.101533_bib36","doi-asserted-by":"crossref","first-page":"3981","DOI":"10.1172\/JCI82416","article-title":"Isolation of neoantigen-specific T cells from tumor and peripheral lymphocytes","volume":"125","author":"Cohen","year":"2015","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.crmeth.2026.101533_bib37","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/s41586-018-0130-2","article-title":"Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates","volume":"557","author":"Simoni","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.crmeth.2026.101533_bib38","doi-asserted-by":"crossref","first-page":"4992","DOI":"10.1172\/JCI127967","article-title":"Recognition of human gastrointestinal cancer neoantigens by circulating PD-1+ lymphocytes","volume":"129","author":"Gros","year":"2019","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.crmeth.2026.101533_bib39","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s13073-019-0697-8","article-title":"Neoantigen-specific immunity in low mutation burden colorectal cancers of the consensus molecular subtype 4","volume":"11","author":"van den Bulk","year":"2019","journal-title":"Genome Med."},{"key":"10.1016\/j.crmeth.2026.101533_bib40","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/s41587-024-02210-6","article-title":"Discovery of tumor-reactive T cell receptors by massively parallel library synthesis and screening","volume":"43","author":"Moravec","year":"2025","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.crmeth.2026.101533_bib41","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/s41467-024-55420-6","article-title":"Enabling next-generation engineered TCR-T therapies based on high-throughput TCR discovery from diagnostic tumor biopsies","volume":"16","author":"Kuilman","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.crmeth.2026.101533_bib42","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1016\/j.ccell.2023.11.005","article-title":"Phenotypic signatures of circulating neoantigen-reactive CD8+ T cells in patients with metastatic cancers","volume":"41","author":"Yossef","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.crmeth.2026.101533_bib43","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1158\/1078-0432.CCR-19-1874","article-title":"Antigen Experienced T Cells from Peripheral Blood Recognize p53 Neoantigens","volume":"26","author":"Malekzadeh","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.crmeth.2026.101533_bib44","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/s41467-019-08304-z","article-title":"Memory T cells targeting oncogenic mutations detected in peripheral blood of epithelial cancer patients","volume":"10","author":"Cafri","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.crmeth.2026.101533_bib45","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1126\/science.aaf2834","article-title":"The \u201ccancer immunogram.\u201d","volume":"352","author":"Blank","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.crmeth.2026.101533_bib46","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/nrc.2016.97","article-title":"Engineered T cells: the promise and challenges of cancer immunotherapy","volume":"16","author":"Fesnak","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.crmeth.2026.101533_bib47","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41571-018-0142-8","article-title":"Cancer immunoediting and resistance to T cell-based immunotherapy","volume":"16","author":"O\u2019Donnell","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.crmeth.2026.101533_bib48","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.1016\/j.celrep.2018.05.068","article-title":"Notch Signaling Facilitates In Vitro Generation of Cross-Presenting Classical Dendritic Cells","volume":"23","author":"Kirkling","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.crmeth.2026.101533_bib49","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1016\/j.celrep.2018.07.033","article-title":"Large-Scale Human Dendritic Cell Differentiation Revealing Notch-Dependent Lineage Bifurcation and Heterogeneity","volume":"24","author":"Balan","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.crmeth.2026.101533_bib50","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1007\/s00262-021-02899-3","article-title":"Clinically applicable CD34+-derived blood dendritic cell subsets exhibit key subset-specific features and potently boost anti-tumor T and NK cell responses","volume":"70","author":"van Eck van der Sluijs","year":"2021","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.crmeth.2026.101533_bib51","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.stemcr.2015.04.012","article-title":"Identification of the Common Origins of Osteoclasts, Macrophages, and Dendritic Cells in Human Hematopoiesis","volume":"4","author":"Xiao","year":"2015","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.crmeth.2026.101533_bib52","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1182\/blood.2020005209","article-title":"Bone marrow\u2013derived myeloid progenitors as driver mutation carriers in high- and low-risk Langerhans cell histiocytosis","volume":"136","author":"Xiao","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.crmeth.2026.101533_bib53","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/term.250","article-title":"Dexamethasone treatment during the expansion phase maintains stemness of bone marrow mesenchymal stem cells","volume":"4","author":"Xiao","year":"2010","journal-title":"J. Tissue Eng. Regen. Med."},{"key":"10.1016\/j.crmeth.2026.101533_bib54","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.exphem.2005.03.017","article-title":"A human stromal-based serum-free culture system supports the ex vivo expansion\/maintenance of bone marrow and cord blood hematopoietic stem\/progenitor cells","volume":"33","author":"da Silva","year":"2005","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.crmeth.2026.101533_bib55","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/(SICI)1097-4652(199807)176:1<57::AID-JCP7>3.0.CO;2-7","article-title":"Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells","volume":"176","author":"Majumdar","year":"1998","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.crmeth.2026.101533_bib56","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/cyto.a.24269","article-title":"Comprehensive Phenotyping of Human Dendritic Cells and Monocytes","volume":"99","author":"Mair","year":"2021","journal-title":"Cytometry. A."},{"key":"10.1016\/j.crmeth.2026.101533_bib57","doi-asserted-by":"crossref","DOI":"10.1126\/science.aag3009","article-title":"Mapping the human DC lineage through the integration of high-dimensional techniques","volume":"356","author":"See","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.crmeth.2026.101533_bib58","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.trsl.2015.07.008","article-title":"Antitumor dendritic cell-based vaccines: lessons from 20 years of clinical trials and future perspectives","volume":"168","author":"Constantino","year":"2016","journal-title":"Transl. Res."},{"key":"10.1016\/j.crmeth.2026.101533_bib59","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nm.2071","article-title":"Generation of stable monoclonal antibody-producing B cell receptor-positive human memory B cells by genetic programming","volume":"16","author":"Kwakkenbos","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.crmeth.2026.101533_bib60","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.trecan.2018.09.001","article-title":"The Role of Type 1 Conventional Dendritic Cells in Cancer Immunity","volume":"4","author":"B\u00f6ttcher","year":"2018","journal-title":"Trends Cancer"},{"key":"10.1016\/j.crmeth.2026.101533_bib61","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1158\/2326-6066.CIR-25-0034","article-title":"Harnessing Notch Signaling to Enhance the Generation and Functionality of Human Conventional Type 1 Dendritic Cells for Cancer Immunotherapy Applications","volume":"13","author":"Balan","year":"2025","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.crmeth.2026.101533_bib62","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.01014","article-title":"Beyond cDC1: Emerging Roles of DC Crosstalk in Cancer Immunity","volume":"10","author":"Noubade","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.crmeth.2026.101533_bib63","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/s41590-023-01517-x","article-title":"CD4+ T cell calibration of antigen-presenting cells optimizes antiviral CD8+ T cell immunity","volume":"24","author":"Gressier","year":"2023","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.crmeth.2026.101533_bib64","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1007\/s00262-011-1004-8","article-title":"Successful treatment of metastatic melanoma by adoptive transfer of blood-derived polyclonal tumor-specific CD4+ and CD8+ T cells in combination with low-dose interferon-alpha","volume":"60","author":"Verdegaal","year":"2011","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.crmeth.2026.101533_bib65","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-007697","article-title":"Timed adoptive T cell transfer during chemotherapy in patients with recurrent platinum-sensitive epithelial ovarian cancer","volume":"11","author":"Verdegaal","year":"2023","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.crmeth.2026.101533_bib66","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.00702","article-title":"Prolonged Persistence of Chimeric Antigen Receptor (CAR) T Cell in Adoptive Cancer Immunotherapy: Challenges and Ways Forward","volume":"11","author":"Jafarzadeh","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.crmeth.2026.101533_bib67","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.cell.2017.01.017","article-title":"Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy","volume":"168","author":"Sharma","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.crmeth.2026.101533_bib68","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.ccell.2015.02.015","article-title":"Macrophages and Therapeutic Resistance in Cancer","volume":"27","author":"Ruffell","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.crmeth.2026.101533_bib69","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1002\/eji.201847659","article-title":"Targeting Treg cells in cancer immunotherapy","volume":"49","author":"Tanaka","year":"2019","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.crmeth.2026.101533_bib70","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/s41568-019-0235-4","article-title":"CD8+ T cell states in human cancer: insights from single-cell analysis","volume":"20","author":"van der Leun","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.crmeth.2026.101533_bib71","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/s41577-021-00574-3","article-title":"CD8+ T cell differentiation and dysfunction in cancer","volume":"22","author":"Philip","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.crmeth.2026.101533_bib72","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abg5669","article-title":"CD8 + T cells specific for conserved coronavirus epitopes correlate with milder disease in patients with COVID-19","volume":"6","author":"Mallajosyula","year":"2021","journal-title":"Sci. Immunol."}],"container-title":["Cell Reports Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667237526002341?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667237526002341?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T14:52:41Z","timestamp":1790002361000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667237526002341"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":72,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2667237526002341"],"URL":"https:\/\/doi.org\/10.1016\/j.crmeth.2026.101533","relation":{},"ISSN":["2667-2375"],"issn-type":[{"value":"2667-2375","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficient generation of human cDC1-like cells to detect and enhance tumor-reactive T cells via CD4+ T cell help","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.crmeth.2026.101533","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101533"}}